Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

PSMC1 Inhibitors

PSMC1 inhibitors belong to a specific chemical class that targets the 19S regulatory subunit of the proteasome. Proteasomes are large protein complexes responsible for the degradation of intracellular proteins, playing a crucial role in maintaining cellular homeostasis and regulating various cellular processes. Within this class of inhibitors, PSMC1 inhibitors specifically interact with the PSMC1 subunit of the 19S regulatory particle, which is responsible for recognizing and unfolding ubiquitinated protein substrates, facilitating their subsequent entry into the proteasome core for degradation. By inhibiting the activity of PSMC1, these compounds disrupt the normal functioning of the proteasome, leading to a perturbation in protein degradation processes. This interference can have significant downstream effects on cellular signaling pathways and protein turnover rates. The inhibition of PSMC1 may result in the accumulation of specific intracellular proteins, altering cellular processes that rely on precise protein levels for regulation.

Understanding the biochemical and cellular effects of PSMC1 inhibitors is vital for unraveling their applications in research and developing future strategies to modulate proteasomal activity for various purposes. As researchers continue to investigate the precise mechanisms and cellular consequences of PSMC1 inhibitors, they may unveil new insights into the regulation of protein degradation and its impact on cellular physiology. The elucidation of PSMC1 inhibitor interactions could have implications for the development of novel approaches. The ongoing research into PSMC1 inhibitors holds promise for expanding our understanding of proteasome function and its intricate role in maintaining cellular integrity and homeostasis.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ixazomib

1072833-77-2sc-489103
sc-489103A
10 mg
50 mg
$311.00
$719.00
(0)

Ixazomib (Ninlaro), like bortezomib and carfilzomib, inhibits the proteasome, including PSMC1, leading to impaired protein degradation and induction of apoptosis in cells.

Delanzomib, free base

847499-27-8sc-396774
sc-396774A
5 mg
10 mg
$160.00
$300.00
(0)

Delanzomib (CEP-18770), a selective proteasome inhibitor, inhibits both chymotrypsin-like and caspase-like activities of the proteasome, including PSMC1, contributing to its properties as a research tool.

Oprozomib

935888-69-0sc-477447
2.5 mg
$280.00
(0)

Oprozomib (ONX 0912), an orally bioavailable proteasome inhibitor, inhibits PSMC1 and other proteasome subunits, offering potential benefits in cellular studies by interfering with protein degradation pathways.

ONX 0914

960374-59-8sc-477437
5 mg
$245.00
(0)

ONX 0914, a selective immunoproteasome inhibitor, targets PSMC1 and other subunits, showing potential in basic research by modulating proteasome activity.